Common Contracts
3 similar Side Letter contracts by Inhibikase Therapeutics, Inc.
June 15, 2018 Joseph Ventures Allium LLC c/o Michael P. Ross New York, NY 10024-1593 Re: Side LetterSide Letter • July 23rd, 2020 • Inhibikase Therapeutics, Inc. • Biological products, (no disgnostic substances)
Reference is made to that certain Subscription Agreement (the “Subscription Agreement”) between Inhibikase Therapeutics, Inc. (the “Company”) and Joseph Ventures Allium LLC (the “Subscriber”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Subscription Agreement.
Re: Side LetterSide Letter • July 23rd, 2020 • Inhibikase Therapeutics, Inc. • Biological products, (no disgnostic substances)
Reference is made to that certain Subscription Agreement (the “Subscription Agreement”) between Inhibikase Therapeutics, Inc. (the “Company”) and Joseph Ventures Allium LLC (the “Subscriber”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Subscription Agreement.
August 31, 2018 Joseph Ventures Allium LLC c/o Michael P. Ross New York, NY 10024-1593 Re: Side LetterSide Letter • July 23rd, 2020 • Inhibikase Therapeutics, Inc. • Biological products, (no disgnostic substances)
Reference is made to that certain Subscription Agreement (the “Subscription Agreement”) between Inhibikase Therapeutics, Inc. (the “Company”) and Joseph Ventures Allium LLC (the “Subscriber”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Subscription Agreement.
